CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Genzyme's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 5, 2025Aav Vectors For Retinal And Cns Gene Therapy1
Mar 23, 2022Methods For Treating Osteogenesis Imperfecta1
Sep 1, 2021High-Density Cell Banking Methods1
Aug 18, 2021Methods And Systems For Processing A Cell Culture1
Jan 6, 2021Methods For Detecting Aav2
Nov 20, 2019Seed Train Processes And Uses Thereof3
Aug 14, 2019Eliglustat (Genz 112638) As Inhibitor Of Glucosylceramide Synthase For Use In A Method Of Treating Fabry'S Or Gaucher'S Disease, The Method Comprising Adjusting The Individual Therapeutical Dose To The P-450 Metabolism Of The Patient3
Aug 7, 2019Methods To Mobilize Progenitor/Stem Cells7

Top competitors of Genzyme

List of top competitors of Genzyme based on patent oppositions.